Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jul 15, 2024; 16(7): 3241-3255
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3241
Published online Jul 15, 2024. doi: 10.4251/wjgo.v16.i7.3241
Figure 5 Phosphatase and tensin homolog knockdown partially reversed inhibitory effects of RNA binding motif 5 on the proliferation, metastasis and glycolysis of colorectal cancer cells.
A: The knockdown efficiency of phosphatase and tensin homolog (PTEN) was detected using Western blot in HCT116 and SW480 cells; B: The expression of PTEN in HCT116 and SW480 cells was detected using Western blot; C: Cell counting kit-8 assay was used to assess the viability of HCT116 and SW480 cells; D: 5-ethynyl-2’-deoxyuridine assay was used to assess proliferation of HCT116 and SW480 cells; E and F: Migration and invasion of HCT116 and SW480 cells were evaluated by transwell assays; G: Glucose consumption, lactic acid production and adenosine-triphosphate production were detected by corresponding kits. aP < 0.05, bP < 0.01, cP < 0.001. PTEN: Phosphatase and tensin homolog.
- Citation: Wang CX, Liu F, Wang Y. RBM5 suppresses proliferation, metastasis and glycolysis of colorectal cancer cells via stabilizing phosphatase and tensin homolog mRNA. World J Gastrointest Oncol 2024; 16(7): 3241-3255
- URL: https://www.wjgnet.com/1948-5204/full/v16/i7/3241.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i7.3241